BioInvent International AB (publ) BINV.ST
BINV.ST
BioInvent International AB (publ) EGTX.ST
Egetis Therapeutics AB (publ) SANION.ST
Saniona AB (publ) DMYD-B.ST
Diamyd Medical AB (publ) VICO.ST
Vicore Pharma Holding AB (publ) ONCO.ST
Oncopeptides AB (publ) XSPRAY.ST
Xspray Pharma AB (publ) SYNACT.ST
SynAct Pharma AB STIL.ST
Stille AB GENO.ST
Genovis AB (publ.)
BioInvent International AB (publ) EGTX.ST
Egetis Therapeutics AB (publ) SANION.ST
Saniona AB (publ) DMYD-B.ST
Diamyd Medical AB (publ) VICO.ST
Vicore Pharma Holding AB (publ) ONCO.ST
Oncopeptides AB (publ) XSPRAY.ST
Xspray Pharma AB (publ) SYNACT.ST
SynAct Pharma AB STIL.ST
Stille AB GENO.ST
Genovis AB (publ.)
Performance
| Periode | BINV.ST | EGTX.ST | SANION.ST | DMYD-B.ST | VICO.ST | ONCO.ST | XSPRAY.ST | SYNACT.ST | STIL.ST | GENO.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -7.12 % | 49.23 % | 109.02 % | 39.72 % | 49.14 % | 169.63 % | -29.55 % | 20.16 % | -6.47 % | -3.17 % |
| YTD | -34.13 % | -18.03 % | 94.16 % | -36.69 % | 22.11 % | 225.95 % | -40.68 % | 132.09 % | -12.15 % | -6.15 % |
| 1Y | -36.79 % | 26.80 % | 259.15 % | -16.92 % | 34.92 % | 146.41 % | -55.83 % | 143.82 % | -17.18 % | 3.15 % |
| 3Y | -32.60 % | 45.50 % | 410.85 % | -17.75 % | -58.96 % | -41.68 % | -55.00 % | -55.80 % | 54.10 % | -38.11 % |
| 5Y | -28.18 % | 0.61 % | -35.03 % | -65.61 % | -42.97 % | -95.64 % | -81.55 % | -51.78 % | 131.53 % | -20.35 % |
| 10Y | -56.70 % | -81.87 % | 25.85 % | 80.01 % | 87.11 % | -83.19 % | -16.88 % | 334.78 % | 980.46 % | 1 002.14 % |
| From the beginning | -97.11 % | -57.26 % | 221.62 % | 228.87 % | 87.11 % | -83.19 % | -16.88 % | 334.78 % | 398.78 % | -53.21 % |